The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(4-(2-Benzoylhydrazine-1-carbonyl)benzyl)-3-chloro-4-fluorobenzamide ID: ALA4549361
PubChem CID: 155550574
Max Phase: Preclinical
Molecular Formula: C22H17ClFN3O3
Molecular Weight: 425.85
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C(NCc1ccc(C(=O)NNC(=O)c2ccccc2)cc1)c1ccc(F)c(Cl)c1
Standard InChI: InChI=1S/C22H17ClFN3O3/c23-18-12-17(10-11-19(18)24)20(28)25-13-14-6-8-16(9-7-14)22(30)27-26-21(29)15-4-2-1-3-5-15/h1-12H,13H2,(H,25,28)(H,26,29)(H,27,30)
Standard InChI Key: LTNAAYHXSGMNBR-UHFFFAOYSA-N
Molfile:
RDKit 2D
30 32 0 0 0 0 0 0 0 0999 V2000
25.0821 -3.2445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0855 -2.4226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3744 -2.0142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6617 -2.4230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6645 -3.2486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3762 -3.6573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9492 -2.0155 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2421 -2.4252 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
21.5297 -2.0178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8185 -2.4275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.5284 -1.1964 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.1074 -2.0168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3967 -2.4258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3975 -3.2480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.1149 -3.6594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8227 -3.2439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6868 -3.6628 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
18.6844 -2.0180 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
25.7938 -3.6573 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7937 -4.4786 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.5057 -3.2447 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.2175 -3.6576 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.9294 -3.2450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.6370 -3.6578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.9295 -2.4237 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.6318 -4.4791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3427 -4.8878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0556 -4.4792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0532 -3.6537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3416 -3.2446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
9 11 2 0
10 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 10 1 0
14 17 1 0
13 18 1 0
1 19 1 0
19 20 2 0
19 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
23 25 2 0
24 26 2 0
26 27 1 0
27 28 2 0
28 29 1 0
29 30 2 0
30 24 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 425.85Molecular Weight (Monoisotopic): 425.0942AlogP: 3.48#Rotatable Bonds: 5Polar Surface Area: 87.30Molecular Species: NEUTRALHBA: 3HBD: 3#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.55CX Basic pKa: ┄CX LogP: 3.63CX LogD: 3.63Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.55Np Likeness Score: -1.60
References 1. Summer SL, Kell SA, Zhu Z, Moore R, Liotta DC, Myers SJ, Koszalka GW, Traynelis SF, Menaldino DS.. (2019) Di-aryl Sulfonamide Motif Adds π-Stacking Bulk in Negative Allosteric Modulators of the NMDA Receptor., 10 (3): [PMID:30891121 ] [10.1021/acsmedchemlett.8b00395 ]